BeStock  
Markets › Compare › BBIO vs BNTX

BBIO vs BNTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BBIO · BridgeBio Pharma$76.03 ▼ 2.75%
BNTX · BioNTech$80.96 ▼ 0.52%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

8193105118130Nov 24, '25May 26, '26Nov 20, '26
  • BBIO +7.1%
  • BNTX -16.1%

Head to head

MetricBBIOBNTX
Price$76.03$80.96
Change today▼ 2.75%▼ 0.52%
Market cap$14.81B$20.07B
Return, 3 months-6.2%-28.2%
Return, year to date-0.6%-15.0%
Return, 1 year+11.6%-15.3%
P/E (TTM)––
P/B-5.71.0
P/E percentile vs own 5y1st44th
Dividend yield––
Revenue growth (YoY, latest qtr)+192.6%-15.1%
Net profit growth (YoY)+67.3%+742.9%
Gross margin94.3%75.0%
Operating margin-37.3%-72.7%
Net margin-62.6%-60.9%
Return on equity–-8.1%
Analyst target vs. price+44.7%+47.4%
Analyst buy share94%75%
RSI (14)5531
30-day volatility37.8%35.9%
Max drawdown, 1 year-29.8%-32.2%
Trend readLeaning bullishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BNTX is the largest of the group by market value.
  • BBIO has returned the most over the past year.
  • BBIO is growing revenue fastest.
  • BNTX keeps the most profit per dollar of sales.
  • BNTX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top